Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
64,290 ILa | -2.74% |
|
+2.98% | -11.32% |
06-14 | Morgan Stanley Adjusts Price Target on NICE to $240 From $290, Maintains Overweight Rating | MT |
06-12 | RBC Capital Cuts Price Target on NICE to $230 From $265, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 10.97B | |
+17.69% | 3,289B | |
+14.62% | 90.43B | |
+14.59% | 85.57B | |
+37.27% | 52.49B | |
-19.27% | 50.25B | |
+32.93% | 46.79B | |
+83.75% | 42.74B | |
-32.70% | 41.67B | |
-1.24% | 27.82B |
- Stock Market
- Equities
- NICE Stock
- News NICE Ltd.
- Transcript : NICE Ltd., Q1 2024 Earnings Call, May 16, 2024